MultiSurv: Long-term cancer survival prediction using multimodal deep learning
View ORCID ProfileLuís A. Vale-Silva, Karl Rohr
doi: https://doi.org/10.1101/2020.08.06.20169698
Luís A. Vale-Silva
Biomedical Computer Vision Group, BioQuant Center and Institute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Germany
Karl Rohr
Biomedical Computer Vision Group, BioQuant Center and Institute of Pharmacy and Molecular Biotechnology (IPMB), Heidelberg University, Germany

Article usage
Posted August 07, 2020.
MultiSurv: Long-term cancer survival prediction using multimodal deep learning
Luís A. Vale-Silva, Karl Rohr
medRxiv 2020.08.06.20169698; doi: https://doi.org/10.1101/2020.08.06.20169698
Subject Area
Subject Areas
- Addiction Medicine (269)
- Allergy and Immunology (552)
- Anesthesia (135)
- Cardiovascular Medicine (1754)
- Dermatology (173)
- Emergency Medicine (312)
- Epidemiology (10796)
- Gastroenterology (588)
- Genetic and Genomic Medicine (2946)
- Geriatric Medicine (287)
- Health Economics (533)
- Health Informatics (1925)
- Health Policy (836)
- Hematology (291)
- HIV/AIDS (630)
- Medical Education (299)
- Medical Ethics (86)
- Nephrology (324)
- Neurology (2796)
- Nursing (151)
- Nutrition (433)
- Oncology (1463)
- Ophthalmology (444)
- Orthopedics (172)
- Otolaryngology (255)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (380)
- Pediatrics (866)
- Primary Care Research (337)
- Public and Global Health (5363)
- Radiology and Imaging (1011)
- Respiratory Medicine (726)
- Rheumatology (330)
- Sports Medicine (278)
- Surgery (327)
- Toxicology (47)
- Transplantation (150)
- Urology (125)